Hai cercato la traduzione di adrenoceptor da Inglese a Maltese

beta2-adrenoceptor agonist (long acting)
beta2-adrenoceptor agonist (iħalli effett fit-tul)

formoterol is a potent selective β2-adrenoceptor agonist.
formoterol huwa agonist β2-adrenoċettur selettiv.

mirabegron is a potent and selective beta 3-adrenoceptor agonist.
mirabegron huwa beta 3-adrenoceptor agonist qawwi u selettiv.

all treatment arms used a short-acting β2 adrenoceptor agonist as needed.
il-fergħat kollha tal-kura użaw agonist tal-andrenoriċetturi β2 li jaħdem malajr kif meħtieġ.

therefore beta 3-adrenoceptor stimulation should not interfere with the voiding process.
għaldaqstant, l-istimulazzjoni ta‟ beta 3-adrenoceptors m‟għandhiex tinterferixxi mal-proċess tat-tbattil.

the active substance in dexdomitor, dexmedetomidine, is an alpha2-adrenoceptor agonist.
is- sustanza attiva f’ dexdomitor, dexmedetomidine, hija agonista ta ’ l - alpha2- adrenoceptor.

the activation of the m2 pathway also inhibits beta 3-adrenoceptor induced increases in camp.
l-attivazzjoni tal-mogħdija m2 tinibixxi wkoll żidiet indotti ta‟ beta 3-adrenoceptors fis-camp.

/inhalation twice daily), and a short acting β2 adrenoceptor agonist as needed.
80 mikrogramma/4.5 mikrogramma/inalazzjoni darbtejn kuljum), u agonist tal-andrenoriċetturi β2 kif meħtieġ.

the cardiovascular malformations observed in the rabbit were shown to be mediated via activation of the beta 1-adrenoceptor.
il- malformazzjonijiet kardjovaskulari osservati fil-fenek kienu jidhru li huma medjati permezz tal- attivazzjoni tal-beta 1-adrenoceptor.

dexmedetomidine is a potent and selective α2-adrenoceptor agonist that inhibits the release of noradrenaline from noradrenergic neurons.
dexmedetomidine huwa α2-adrenoceptor agonist qawwi u selettiv li jimblokka l-ħruġ ta’ noradrenalina minn newroni noradrenerġiċi.

also the use of the alpha-1 adrenoceptor antagonist alfuzosin, and sildenafil when used for the treatment of pulmonary arterial hypertension.
l-użu tal-alpha-1 adrenoceptor antagonist alfuzosin u sildenafil meta jintuża għall-kura ta’ pressjoni għolja arterjali pulmonari wkoll.

an overdose of formoterol would likely lead to effects that are typical for β2 adrenoceptor agonists: tremor, headache, palpitations.
doża eċċessiva ta’ formoterol x’aktarx twassal għal effetti li huma tipiċi għall-agonisti tal- adrenoriċetturi β2: tregħid, uġigħ ta’ ras, palpitazzjonijiet.

noradrenaline is released from nerve terminals, leading predominantly to beta adrenoceptor activation in the bladder musculature, and hence bladder smooth muscle relaxation.
noradrenalina tiġi rilaxxata mit-terminali tan-nervituri, u dan iwassal fil-parti l-kbira għall-attivazzjoni ta‟ beta adrenoceptors fil-muskulatura tal-bużżieqa tal-awrina, u għalhekk għar- rilassament tal-muskolu lixx tal-bużżieqa tal-awrina.

/4.5 micrograms/inhalation twice daily), and a short acting β2 adrenoceptor agonist as needed.
80 mikrogramma/4.5 mikrogramma/inalazzjoni darbtejn kuljum), u agonist tal-andrenoriċetturi β2 kif meħtieġ.

80 micrograms/4.5 micrograms/inhalation twice daily), and a short acting β2 adrenoceptor agonist as needed.
80 mikrogramma/4.5 mikrogramma/inalazzjoni darbtejn kuljum), u agonist tal-andrenoriċetturi β2 kif meħtieġ.

the applicant stated that the presented in vitro data can be predictive of pharmacokinetic bioequivalence for cmax and for peak airway and systemic beta-2 adrenoceptor mediated responses, which are mainly determined by lung bioavailability.
l - applikant iddikjara li d- dejta ppreżentata in vitro tista ’ tkun ta ’ tbassir għall- bijoekwivalenza farmakokinetika għas- cmax u għar- risponsi massimi tal- passaġġi tal- arja u sistemiċi medjati minn riċettur beta- 2 adrenerġiku (adrenoceptor), li huma prinċiplament iddeterminati mill- bijodisponibbiltà tal- pulmun.

dexmedetomidine also induces a number of other α2-adrenoceptor mediated effects, which include piloerection, depression of motor and secretory functions of the gastrointestinal tract, diuresis and hyperglycaemia.
dexmedetomidine iwassal ukoll għal effetti oħra li huma α2-adrenoceptor mediated.

formoterol fumarate dihydrate belongs to a group of medicines called ‘long-acting β2 adrenoceptor agonists’ or ‘bronchodilators’.
formoterol fumarate dihydrate jappartjeni għal grupp ta’ mediċini msejħa’agonisti tal- adrenoriċetturi β2 li jaħdmu fit-tul’ jew ‘bronkodilaturi’ .

biresp spiromax is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:
biresp spiromax hu indikat għat-trattament regolari tal-ażma, fejn l-użu ta’ kombinazzjoni (kortikosterojd li jittieħed man-nifs u agonist tal-adrenoriċetturi β2 li jaħdem fit-tul) ikun adattat:

budesonide/formoterol teva is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:
budesonide/formoterol teva hu indikat għat-trattament regolari tal-ażma, fejn l-użu ta’ kombinazzjoni (kortikosterojd li jittieħed man-nifs u agonist tal-adrenoriċetturi β2 li jaħdem fit-tul) ikun adattat: